98,072 XNAS Volume
XNAS 15 Apr, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Peter J. Mariani | Chief Financial Officer | 24 Feb 2025 | 32,625 | 0 | - | - | Series A Right Warrants (right to buy) | ||
| Peter J. Mariani | Chief Financial Officer | 24 Feb 2025 | 32,625 | 466,613 (1%) | 0% | 1.1 | 36,866 | Common Stock | |
| Vincent J. Capponi | President and COO | 24 Feb 2025 | 12,000 | 677,168 (1%) | 0% | 1.1 | 13,560 | Common Stock | |
| Vincent J. Capponi | President and COO | 24 Feb 2025 | 12,000 | 0 | - | - | Series A Right Warrants (right to buy) | ||
| Phillip P. Chan | Director, Chief Executive Officer | 24 Feb 2025 | 34,168 | 0 | - | - | Series A Right Warrants (right to buy) | ||
| Phillip P. Chan | Director, Chief Executive Officer | 24 Feb 2025 | 34,168 | 1,277,363 (3%) | 0% | 1.1 | 38,610 | Common Stock | |
| Alan D. Sobel | Director | 24 Feb 2025 | 21,950 | 0 | - | - | Series A Right Warrants (right to buy) | ||
| Alan D. Sobel | Director | 24 Feb 2025 | 21,950 | 145,757 (0%) | 0% | 1.1 | 24,804 | Common Stock | |
| Michael G. Bator | Director | 24 Feb 2025 | 15,879 | 0 | - | - | Series A Right Warrants (right to buy) | ||
| Michael G. Bator | Director | 24 Feb 2025 | 10,000 | 151,273 (0%) | 0% | 1.1 | 11,300 | Common Stock | |
| Peter J. Mariani | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 32,625 | 32,625 | - | - | Series B Right Warrants | |
| Peter J. Mariani | Chief Financial Officer | 17 Jan 2025 | 32,625 | 433,988 (1%) | 0% | 1 | 32,625 | Common Stock | |
| Peter J. Mariani | Chief Financial Officer | 17 Jan 2025 | 32,625 | 0 | - | - | Subscription Rights (right to buy) | ||
| Peter J. Mariani | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 32,625 | 32,625 | - | - | Series A Right Warrants | |
| Vincent J. Capponi | President and COO | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 31,760 | 31,760 | - | - | Series B Right Warrants | |
| Vincent J. Capponi | President and COO | 17 Jan 2025 | 31,760 | 665,168 (1%) | 0% | 1 | 31,760 | Common Stock | |
| Vincent J. Capponi | President and COO | 17 Jan 2025 | 31,760 | 0 | - | - | Subscription Rights (right to buy) | ||
| Vincent J. Capponi | President and COO | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 31,760 | 31,760 | - | - | Series A Right Warrants | |
| Phillip P. Chan | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 90,832 | 90,832 | - | - | Series A Right Warrants | |
| Phillip P. Chan | Director, Chief Executive Officer | 17 Jan 2025 | 90,832 | 1,243,195 (3%) | 0% | 1 | 90,832 | Common Stock | |
| Phillip P. Chan | Director, Chief Executive Officer | 17 Jan 2025 | 90,832 | 0 | - | - | Subscription Rights (right to buy) | ||
| Phillip P. Chan | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 90,832 | 90,832 | - | - | Series B Right Warrants | |
| Alan D. Sobel | Director | 17 Jan 2025 | 21,950 | 123,807 (0%) | 0% | 1 | 21,950 | Common Stock | |
| Alan D. Sobel | Director | 17 Jan 2025 | 21,950 | 0 | - | - | Subscription Rights (right to buy) | ||
| Alan D. Sobel | Director | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 21,950 | 21,950 | - | - | Series A Right Warrants | |
| Alan D. Sobel | Director | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 21,950 | 21,950 | - | - | Series B Right Warrants | |
| Michael G. Bator | Director | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 15,879 | 15,879 | - | - | Series B Right Warrants | |
| Michael G. Bator | Director | 17 Jan 2025 | 15,879 | 141,273 (0%) | 0% | 1 | 15,879 | Common Stock | |
| Michael G. Bator | Director | 17 Jan 2025 | 15,879 | 0 | - | - | Subscription Rights (right to buy) | ||
| Michael G. Bator | Director | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 15,879 | 15,879 | - | - | Series A Right Warrants | |
| Efthymios Nikolaos Deliargyris | Chief Medical Officer | 17 Jan 2025 | 16,233 | 403,025 (1%) | 0% | 1 | 16,233 | Common Stock | |
| Efthymios Nikolaos Deliargyris | Chief Medical Officer | 17 Jan 2025 | 16,233 | 0 | - | - | Subscription Rights (right to buy) | ||
| Efthymios Nikolaos Deliargyris | Chief Medical Officer | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 16,233 | 16,233 | - | - | Series A Right Warrants | |
| Efthymios Nikolaos Deliargyris | Chief Medical Officer | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 16,233 | 16,233 | - | - | Series B Right Warrants | |
| Peter J. Mariani | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.96 per share. | 13 Dec 2024 | 20,000 | 401,363 (1%) | 0% | 1.0 | 19,294 | Common Stock |
| Peter J. Mariani | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.89 per share. | 11 Dec 2024 | 20,000 | 381,363 (1%) | 0% | 0.9 | 17,872 | Common Stock |
| Peter J. Mariani | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.89 per share. | 11 Dec 2024 | 11,363 | 361,363 (1%) | 0% | 0.9 | 10,103 | Common Stock |
| Vincent J. Capponi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Vincent J. Capponi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Efthymios Nikolaos Deliargyris | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Efthymios Nikolaos Deliargyris | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Peter J. Mariani | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 110,000 | 110,000 (0%) | 0% | 0 | Common Stock | |
| Peter J. Mariani | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 215,000 | 215,000 | - | - | Stock Option (right to buy) | |
| Peter J. Mariani | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Peter J. Mariani | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 175,000 | 350,000 (0%) | 0% | 0 | Common Stock | |
| Peter J. Mariani | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 65,000 | 175,000 (0%) | 0% | 0 | Common Stock | |
| Edward R. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 87,000 | 87,000 | - | - | Stock Option (Right to Buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 65,000 | 532,941 (1%) | 0% | 0 | Common Stock | |
| Vincent J. Capponi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 101,000 | 101,000 | - | - | Stock Option (Right to Buy) | |
| Vincent J. Capponi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 81,000 | 665,134 (1%) | 0% | 0 | Common Stock | |
| Phillip P. Chan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 124,000 | 124,000 | - | - | Stock Option (Right to Buy) | |
| Phillip P. Chan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 96,000 | 1,164,704 (3%) | 0% | 0 | Common Stock | |
| Alan D. Sobel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Michael G. Bator | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Efthymios Nikolaos Deliargyris | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 61,000 | 409,433 (1%) | 0% | 0 | Common Stock | |
| Efthymios Nikolaos Deliargyris | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 86,000 | 86,000 | - | - | Stock Option (Right to Buy) | |
| Jiny Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 49,038 | 49,038 | - | - | Stock Option (Right to Buy) | |
| Phillip P. Chan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 129,998 | 129,998 | - | - | Stock Option (Right to Buy) | |
| Efthymios Deliargyris | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 47,088 | 47,088 | - | - | Stock Option (Right to Buy) | |
| Vincent Capponi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2024 | 48,923 | 48,923 | - | - | Stock Option (Right to Buy) | |
| Capponi Vincent | President & COO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Dec 2023 | 6,578 | 6,578 | - | - | Common Stock Warrant (Right to Buy) | |
| G. Michael Bator | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Dec 2023 | 13,157 | 13,157 | - | - | Common Stock Warrant (Right to Buy) | |
| Bloch Kathleen P. | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 13 Dec 2023 | 37,594 | 467,941 (1%) | 0% | 1.3 | 50,000 | Common Stock |
| Kim Jiny | Director | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 13 Dec 2023 | 7,519 | 77,819 (0%) | 0% | 1.3 | 10,000 | Common Stock |
| P. Phillip Chan | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 13 Dec 2023 | 75,188 | 1,068,704 (3%) | 0% | 1.3 | 100,000 | Common Stock |
| Vincent Capponi | President & COO | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 13 Dec 2023 | 18,797 | 584,134 (1%) | 0% | 1.3 | 25,000 | Common Stock |
| D. Alan Sobel | Director | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 13 Dec 2023 | 22,557 | 101,857 (0%) | 0% | 1.3 | 30,001 | Common Stock |
| Bloch P. Kathleen | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Dec 2023 | 13,157 | 13,157 | - | - | Common Stock Warrant (Right to Buy) | |
| Deliargyris Efthymios | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 13 Dec 2023 | 22,557 | 348,433 (0%) | 0% | 1.3 | 30,001 | Common Stock |
| Jones Edward R. | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Dec 2023 | 2,631 | 2,631 | - | - | Common Stock Warrant (Right to Buy) | |
| Phillip P. Chan | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Dec 2023 | 26,315 | 26,315 | - | - | Common Stock Warrant (Right to Buy) | |
| Alan Sobel D. | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Dec 2023 | 7,894 | 7,894 | - | - | Common Stock Warrant (Right to Buy) | |
| Jones R. Edward | Director | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 13 Dec 2023 | 7,519 | 88,834 (0%) | 0% | 1.3 | 10,000 | Common Stock |
| G. Michael Bator | Director | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 13 Dec 2023 | 37,594 | 125,394 (0%) | 0% | 1.3 | 50,000 | Common Stock |
| Efthymios Deliargyris | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Dec 2023 | 7,894 | 7,894 | - | - | Common Stock Warrant (Right to Buy) | |
| Kim Jiny | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Dec 2023 | 2,631 | 2,631 | - | - | Common Stock Warrant (Right to Buy) | |
| Michael G. Bator | Director | Purchase of securities on an exchange or from another person at price $ 3.23 per share. | 04 Aug 2023 | 1,000 | 85,800 (0%) | 0% | 3.2 | 3,230 | Common Stock |
| Michael G. Bator | Director | Purchase of securities on an exchange or from another person at price $ 3.15 per share. | 04 Aug 2023 | 1,000 | 87,800 (0%) | 0% | 3.2 | 3,150 | Common Stock |
| Michael G. Bator | Director | Purchase of securities on an exchange or from another person at price $ 3.20 per share. | 04 Aug 2023 | 1,000 | 86,800 (0%) | 0% | 3.2 | 3,200 | Common Stock |
| Edward R. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Kathleen P. Bloch | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Vincent Capponi | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2023 | 91,000 | 91,000 | - | - | Stock Option (right to buy) | |
| Vincent Capponi | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2023 | 42,000 | 42,000 | - | - | Stock Option (right to buy) | |
| Vincent Capponi | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2023 | 73,000 | 576,153 (1%) | 0% | 0 | Common Stock | |
| Phillip P. Chan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2023 | 87,000 | 1,006,548 (2%) | 0% | 0 | Common Stock | |
| Phillip P. Chan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2023 | 112,000 | 112,000 | - | - | Stock Option (right to buy) | |
| Phillip P. Chan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2023 | 48,000 | 48,000 | - | - | Stock Option (right to buy) | |
| Alan D. Sobel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Michael G. Bator | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Efthymios Deliargyris | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Efthymios Deliargyris | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2023 | 55,000 | 331,648 (0%) | 0% | 0 | Common Stock | |
| Efthymios Deliargyris | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2023 | 78,000 | 78,000 | - | - | Stock Option (right to buy) | |
| Jiny Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Kathleen P. Bloch | Interim CFO | Purchase of securities on an exchange or from another person at price $ 2.84 per share. | 25 May 2023 | 1,100 | 45,900 (0%) | 0% | 2.8 | 3,123 | Common Stock |
| Kathleen P. Bloch | Interim CFO | Purchase of securities on an exchange or from another person at price $ 2.85 per share. | 25 May 2023 | 1,100 | 44,800 (0%) | 0% | 2.8 | 3,133 | Common Stock |
| Kathleen P. Bloch | Interim CFO | Purchase of securities on an exchange or from another person at price $ 2.85 per share. | 25 May 2023 | 1,100 | 47,000 (0%) | 0% | 2.8 | 3,133 | Common Stock |
| Kathleen P. Bloch | Interim CFO | Purchase of securities on an exchange or from another person at price $ 3.06 per share. | 10 May 2023 | 5,000 | 38,700 (0%) | 0% | 3.1 | 15,298 | Common Stock |
| Kathleen P. Bloch | Interim CFO | Purchase of securities on an exchange or from another person at price $ 3.17 per share. | 10 May 2023 | 3,000 | 43,700 (0%) | 0% | 3.2 | 9,510 | Common Stock |
| Kathleen P. Bloch | Interim CFO | Purchase of securities on an exchange or from another person at price $ 3.12 per share. | 10 May 2023 | 2,000 | 40,700 (0%) | 0% | 3.1 | 6,250 | Common Stock |
| Vincent Capponi | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2023 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
| Vincent Capponi | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.88 per share. | 04 Apr 2023 | 10,000 | 511,989 (1%) | 0% | 2.9 | 28,750 | Common Stock |
| Phillip P. Chan | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.88 per share. | 03 Apr 2023 | 30,500 | 927,779 (2%) | 0% | 2.9 | 87,688 | Common Stock |
| Phillip P. Chan | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 30,500 | 0 | - | - | Stock Option (right to buy) | |
| Alan D. Sobel | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Feb 2023 | 2,000 | 0 (0%) | 0% | 0 | Common Stock | |
| Alan D. Sobel | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Feb 2023 | 2,000 | 81,300 (0%) | 0% | 0 | Common Stock | |
| Al W. Kraus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.65 per share. | 06 Feb 2023 | 12,000 | 142,046 (0%) | 0% | 2.7 | 31,800 | Common Stock |
| Al W. Kraus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 12,000 | 0 | - | - | Stock Option (right to buy) | |
| Phillip P. Chan | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.26 per share. | 06 Dec 2022 | 9,850 | 891,420 (2%) | 0% | 1.3 | 12,411 | Common Stock |
| Phillip P. Chan | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.26 per share. | 06 Dec 2022 | 14,291 | 881,570 (2%) | 0% | 1.3 | 18,064 | Common Stock |
| Phillip P. Chan | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.70 per share. | 08 Sep 2022 | 35,000 | 867,279 (2%) | 0% | 1.7 | 59,500 | Common Stock |
| Jiny Kim | Director | Purchase of securities on an exchange or from another person at price $ 1.91 per share. | 25 Aug 2022 | 1,000 | 70,300 (0%) | 0% | 1.9 | 1,910 | Common Stock |
| Al W. Kraus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 37,950 | 37,950 | - | - | Stock Option (right to buy) | |
| Edward R. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 18,975 | 18,975 | - | - | Stock Option (right to buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 55,500 | 405,161 (1%) | 0% | 0 | Common Stock | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 215,000 | 215,000 | - | - | Stock Option (right to buy) | |
| Vincent Capponi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 86,000 | 86,000 | - | - | Stock Option (right to buy) | |
| Vincent Capponi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 69,000 | 512,545 (1%) | 0% | 0 | Common Stock | |
| Vincent Capponi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Phillip P. Chan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 79,000 | 845,130 (2%) | 0% | 0 | Common Stock | |
| Phillip P. Chan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 240,000 | 240,000 | - | - | Stock Option (right to buy) | |
| Phillip P. Chan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 106,000 | 106,000 | - | - | Stock Option (right to buy) | |
| Alan D. Sobel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 18,975 | 18,975 | - | - | Stock Option (right to buy) | |
| Michael G. Bator | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 18,975 | 18,975 | - | - | Stock Option (right to buy) | |
| Efthymios Deliargyris | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | |
| Efthymios Deliargyris | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 55,000 | 228,384 (0%) | 0% | 0 | Common Stock | |
| Efthymios Deliargyris | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 52,000 | 283,384 (0%) | 0% | 0 | Common Stock | |
| Efthymios Deliargyris | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 74,000 | 74,000 | - | - | Stock Option (right to buy) | |
| Jiny Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 18,975 | 18,975 | - | - | Stock Option (right to buy) | |
| Vincent Capponi | President and COO | Purchase of securities on an exchange or from another person at price $ 1.80 per share. | 21 Jun 2022 | 2,000 | 443,545 (1%) | 0% | 1.8 | 3,600 | Common Stock |
| Vincent Capponi | See Remarks | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 16 Jun 2022 | 3,000 | 441,545 (1%) | 0% | 2 | 6,000 | Common Stock |
| Phillip P. Chan | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 16 Jun 2022 | 2,221 | 768,351 (2%) | 0% | 1.9 | 4,109 | Common Stock |
| Phillip P. Chan | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.17 per share. | 09 Jun 2022 | 16,000 | 766,130 (2%) | 0% | 2.2 | 34,784 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.90 per share. | 06 Jun 2022 | 8,700 | 33,700 (0%) | 0% | 1.9 | 16,529 | Common Stock |
| Vincent Capponi | President and COO | Purchase of securities on an exchange or from another person at price $ 2.02 per share. | 23 May 2022 | 299 | 435,418 (1%) | 0% | 2.0 | 605 | Common Stock |
| Vincent Capponi | President and COO | Purchase of securities on an exchange or from another person at price $ 2.04 per share. | 23 May 2022 | 1,574 | 435,119 (1%) | 0% | 2.0 | 3,211 | Common Stock |
| Vincent Capponi | President and COO | Purchase of securities on an exchange or from another person at price $ 2.03 per share. | 23 May 2022 | 3,127 | 438,545 (1%) | 0% | 2.0 | 6,348 | Common Stock |
| Michael G. Bator | Director | Purchase of securities on an exchange or from another person at price $ 2.21 per share. | 18 May 2022 | 1,000 | 84,800 (0%) | 0% | 2.2 | 2,210 | Common Stock |
| Michael G. Bator | Director | Purchase of securities on an exchange or from another person at price $ 2.20 per share. | 18 May 2022 | 2,000 | 81,800 (0%) | 0% | 2.2 | 4,400 | Common Stock |
| Michael G. Bator | Director | Purchase of securities on an exchange or from another person at price $ 2.20 per share. | 18 May 2022 | 2,000 | 79,800 (0%) | 0% | 2.2 | 4,400 | Common Stock |
| Michael G. Bator | Director | Purchase of securities on an exchange or from another person at price $ 2.18 per share. | 18 May 2022 | 2,000 | 77,800 (0%) | 0% | 2.2 | 4,360 | Common Stock |
| Michael G. Bator | Director | Purchase of securities on an exchange or from another person at price $ 2.18 per share. | 18 May 2022 | 2,000 | 75,800 (0%) | 0% | 2.2 | 4,360 | Common Stock |
| Michael G. Bator | Director | Purchase of securities on an exchange or from another person at price $ 2.20 per share. | 18 May 2022 | 2,000 | 83,800 (0%) | 0% | 2.2 | 4,400 | Common Stock |
| Edward R. Jones | Director | Purchase of securities on an exchange or from another person at price $ 2.24 per share. | 16 May 2022 | 1,676 | 81,315 (0%) | 0% | 2.2 | 3,749 | Common Stock |
| Alan D. Sobel | Director | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 11 May 2022 | 1,200 | 70,500 (0%) | 0% | 2.0 | 2,399 | Common Stock |
| Alan D. Sobel | Director | Purchase of securities on an exchange or from another person at price $ 2.02 per share. | 11 May 2022 | 8,800 | 79,300 (0%) | 0% | 2.0 | 17,776 | Common Stock |
| Al W. Kraus | Director | Purchase of securities on an exchange or from another person at price $ 1.96 per share. | 06 May 2022 | 5,000 | 130,046 (0%) | 0% | 2.0 | 9,795 | Common Stock |
| Jiny Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 17,250 | 17,250 | - | - | Stock Option (Right to Buy) | |
| Jiny Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 69,300 | 69,300 (0%) | 0% | 0 | Common Stock | |
| Alan D. Sobel | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Feb 2022 | 2,000 | 2,000 (0%) | 0% | 0 | Common Stock | |
| Phillip P. Chan | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 5.25 per share. | 10 Dec 2021 | 5,000 | 753,443 (2%) | 0% | 5.3 | 26,250 | Common Stock |
| Edward R. Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2021 | 4,000 | 0 | - | - | Stock Option (right to buy) | |
| Edward R. Jones | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.22 per share. | 09 Dec 2021 | 3,161 | 79,639 (0%) | 0% | 5.2 | 16,500 | Common Stock |
| Edward R. Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 09 Dec 2021 | 4,000 | 82,800 (0%) | 0% | 4.1 | 16,500 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.98 per share. | 23 Nov 2021 | 4,000 | 25,000 (0%) | 0% | 5.0 | 19,920 | Common Stock |
| Al W. Kraus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 31 Aug 2021 | 4,000 | 129,046 (0%) | 0% | 4.1 | 16,500 | Common Stock |
| Al W. Kraus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2021 | 4,000 | 0 | - | - | Stock Option (right to buy) | |
| Al W. Kraus | Director | Sale of securities on an exchange or to another person at price $ 9.40 per share. | 31 Aug 2021 | 4,000 | 125,046 (0%) | 0% | 9.4 | 37,591 | Common Stock |
| Al W. Kraus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 34,500 | 34,500 | - | - | Stock Option (right to buy) | |
| Edward R. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 17,250 | 17,250 | - | - | Stock Option (right to buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 69,000 | 69,000 | - | - | Stock Option (right to buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 8.99 per share. | 12 Apr 2021 | 49,450 | 375,372 (1%) | 0% | 9.0 | 444,556 | Common Stock |
| Vincent Capponi | President, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 8.99 per share. | 12 Apr 2021 | 62,215 | 467,756 (1%) | 0% | 9.0 | 559,313 | Common Stock |
| Vincent Capponi | President, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 78,200 | 78,200 | - | - | Stock Option (right to buy) | |
| Phillip P. Chan | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 8.99 per share. | 12 Apr 2021 | 72,000 | 769,339 (2%) | 0% | 9.0 | 647,280 | Common Stock |
| Phillip P. Chan | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 96,000 | 96,000 | - | - | Stock Option (right to buy) | |
| Alan D. Sobel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 17,250 | 17,250 | - | - | Stock Option (right to buy) | |
| Michael G. Bator | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 17,250 | 17,250 | - | - | Stock Option (right to buy) | |
| Efthymios Deliargyris | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 8.99 per share. | 12 Apr 2021 | 40,000 | 183,000 (0%) | 0% | 9.0 | 359,600 | Common Stock |
| Efthymios Deliargyris | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 63,250 | 63,250 | - | - | Stock Option (right to buy) | |
| Al W. Kraus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2020 | 8,000 | 0 | - | - | Stock Option (right to buy) | |
| Al W. Kraus | Director | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 10 Nov 2020 | 8,000 | 125,046 (0%) | 0% | 8 | 64,000 | Common Stock |
| Al W. Kraus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.45 per share. | 10 Nov 2020 | 8,000 | 133,046 (0%) | 0% | 3.5 | 27,600 | Common Stock |
| Edward R. Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.35 per share. | 18 Aug 2020 | 4,000 | 78,800 (0%) | 0% | 3.4 | 13,400 | Common Stock |
| Edward R. Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2020 | 4,000 | 0 | - | - | Stock Option (right to buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2020 | 10,000 | 55,650 | - | - | Stock Option (right to buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.60 per share. | 31 Jul 2020 | 10,000 | 325,156 (0%) | 0% | 5.6 | 56,000 | Common Stock |
| Vincent Capponi | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2020 | 10,123 | 0 | - | - | Stock Option (right to buy) | |
| Vincent Capponi | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.26 per share. | 05 May 2020 | 10,123 | 427,772 (1%) | 0% | 9.3 | 93,739 | Common Stock |
| Phillip P. Chan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2020 | 14,100 | 0 | - | - | Stock Option (right to buy) | |
| Phillip P. Chan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.39 per share. | 05 May 2020 | 14,100 | 714,682 (2%) | 0% | 9.4 | 132,399 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.88 per share. | 27 Apr 2020 | 10,000 | 427,649 (1%) | 0% | 2.9 | 28,750 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 27 Apr 2020 | 10,000 | 417,649 (1%) | 0% | 10 | 100,000 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2020 | 10,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Efthymios Deliargyris | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2020 | 140,000 | 140,000 (0%) | 0% | 0 | Common Stock | |
| Efthymios Deliargyris | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2020 | 85,500 | 85,500 | - | - | Stock Option (right to buy) | |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2020 | 4,677 | 10,123 | - | - | Stock Option (right to buy) | |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.45 per share. | 10 Mar 2020 | 4,677 | 422,326 (1%) | 0% | 3.5 | 16,136 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.45 per share. | 10 Mar 2020 | 6,500 | 417,649 (1%) | 0% | 3.5 | 22,425 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 10 Mar 2020 | 4,677 | 417,649 (1%) | 0% | 6 | 28,062 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2020 | 6,500 | 14,800 | - | - | Stock Option (right to buy) | |
| Al W. Kraus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2020 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Edward R. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2020 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2020 | 43,000 | 328,828 (0%) | 0% | 0 | Common Stock | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2020 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Vincent Capponi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2020 | 54,100 | 420,849 (1%) | 0% | 0 | Common Stock | |
| Vincent Capponi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2020 | 68,000 | 68,000 | - | - | Stock Option (right to buy) | |
| Phillip P. Chan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2020 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Phillip P. Chan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2020 | 60,000 | 711,178 (2%) | 0% | 0 | Common Stock | |
| Alan D. Sobel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2020 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Michael G. Bator | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2020 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 3.68 per share. | 10 Dec 2019 | 3,000 | 291,895 (0%) | 0% | 3.7 | 11,030 | Common Stock |
| Phillip P. Chan | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.60 per share. | 06 Dec 2019 | 16,500 | 657,688 (1%) | 0% | 3.6 | 59,400 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.27 per share. | 26 Nov 2019 | 1,000 | 21,000 (0%) | 0% | 4.3 | 4,270 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.83 per share. | 16 Aug 2019 | 6,500 | 20,000 (0%) | 0% | 4.8 | 31,395 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2019 | 4,600 | 15,400 | - | - | Stock Option (right to buy) | |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.32 per share. | 16 Aug 2019 | 4,600 | 372,501 (1%) | 0% | 4.3 | 19,895 | Common Stock |
| Phillip P. Chan | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2019 | 75,000 | 14,100 | - | - | Stock Option (right to buy) | |
| Phillip P. Chan | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.45 per share. | 15 Aug 2019 | 75,000 | 641,188 (1%) | 0% | 3.5 | 258,750 | Common Stock |
| Eric R. Mortensen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.50 per share. | 14 Aug 2019 | 5,000 | 148,932 (0%) | 0% | 4.5 | 22,500 | Common Stock |
| Eric R. Mortensen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2019 | 5,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 5.52 per share. | 09 Aug 2019 | 1,500 | 13,500 (0%) | 0% | 5.5 | 8,273 | Common Stock |
| Al W. Kraus | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2019 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Edward R. Jones | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2019 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2019 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2019 | 43,000 | 295,725 (0%) | 0% | 0 | Common Stock | |
| Vincent Capponi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2019 | 68,000 | 68,000 | - | - | Stock Option (right to buy) | |
| Vincent Capponi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2019 | 54,100 | 376,322 (1%) | 0% | 0 | Common Stock | |
| Phillip P. Chan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2019 | 60,000 | 575,582 (1%) | 0% | 0 | Common Stock | |
| Phillip P. Chan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2019 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Alan D. Sobel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2019 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Michael G. Bator | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2019 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Eric R. Mortensen | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2019 | 48,700 | 48,700 | - | - | Stock Option (right to buy) | |
| Eric R. Mortensen | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2019 | 12,200 | 145,612 (0%) | 0% | 0 | Common Stock | |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.60 per share. | 07 Jun 2019 | 10,000 | 252,725 (0%) | 0% | 5.6 | 56,000 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2019 | 10,000 | 65,650 | - | - | Stock Option (right to buy) | |
| Phillip P. Chan | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.32 per share. | 07 Jun 2019 | 20,000 | 515,582 (1%) | 0% | 4.3 | 86,500 | Common Stock |
| Phillip P. Chan | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2019 | 20,000 | 0 | - | - | Stock Option (right to buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 6.49 per share. | 10 May 2019 | 3,000 | 3,000 (0%) | 0% | 6.5 | 19,476 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2019 | 4,070 | 242,725 (0%) | 0% | 0 | Common Stock | |
| Vincent Capponi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2019 | 4,620 | 325,435 (0%) | 0% | 0 | Common Stock | |
| Phillip P. Chan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2019 | 5,500 | 496,383 (1%) | 0% | 0 | Common Stock | |
| Eric R. Mortensen | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2019 | 4,620 | 34,166 (0%) | 0% | 0 | Common Stock | |
| Edward R. Jones | None | 31 Dec 2018 | 1,800 | 0 | - | - | Stock Option (right to buy) | ||
| Edward R. Jones | None | 31 Dec 2018 | 1,200 | 74,800 (0%) | 0% | 2 | 2,400 | Common Stock | |
| Edward R. Jones | None | 31 Dec 2018 | 1,800 | 73,600 (0%) | 0% | 0.9 | 1,575 | Common Stock | |
| Edward R. Jones | None | 31 Dec 2018 | 1,200 | 0 | - | - | Stock Option (right to buy) | ||
| Phillip P. Chan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.37 per share. | 07 Dec 2018 | 24,337 | 503,281 (1%) | 0% | 9.4 | 228,026 | Common Stock |
| Phillip P. Chan | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 07 Dec 2018 | 89,337 | 527,618 (1%) | 0% | 2.1 | 187,608 | Common Stock |
| Phillip P. Chan | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2018 | 89,337 | 0 | - | - | Non-Statutory Stock Option (right to buy) | |
| Phillip P. Chan | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 05 Sep 2018 | 2,900 | 446,968 (1%) | 0% | 2.1 | 6,090 | Common Stock |
| Phillip P. Chan | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 05 Sep 2018 | 5,187 | 444,068 (1%) | 0% | 2.1 | 10,893 | Common Stock |
| Phillip P. Chan | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 05 Sep 2018 | 600 | 438,881 (1%) | 0% | 2 | 1,200 | Common Stock |
| Phillip P. Chan | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2018 | 600 | 0 | - | - | Non-Statutory Stock Option (right to buy) | |
| Phillip P. Chan | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2018 | 2,900 | 92,068 | - | - | Non-Statutory Stock Option (right to buy) | |
| Phillip P. Chan | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2018 | 5,187 | 94,968 | - | - | Non-Statutory Stock Option (right to buy) | |
| Phillip P. Chan | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2018 | 2,731 | 89,337 | - | - | Non-Statutory Stock Option (right to buy) | |
| Phillip P. Chan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 14.11 per share. | 05 Sep 2018 | 2,731 | 438,281 (1%) | 0% | 14.1 | 38,534 | Common Stock |
| Phillip P. Chan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 14.75 per share. | 05 Sep 2018 | 2,900 | 441,012 (1%) | 0% | 14.8 | 42,775 | Common Stock |
| Phillip P. Chan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 14.85 per share. | 05 Sep 2018 | 5,187 | 443,912 (1%) | 0% | 14.9 | 77,027 | Common Stock |
| Phillip P. Chan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 14.85 per share. | 05 Sep 2018 | 600 | 449,099 (1%) | 0% | 14.9 | 8,910 | Common Stock |
| Phillip P. Chan | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 05 Sep 2018 | 2,731 | 449,699 (1%) | 0% | 2.1 | 5,735 | Common Stock |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2018 | 8,000 | 0 | - | - | Stock Option (right to buy) | |
| Al W. Kraus | None | Sale of securities on an exchange or to another person at price $ 14.47 per share. | 30 Aug 2018 | 26,000 | 125,046 (0%) | 0% | 14.5 | 376,282 | Common Stock |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.20 per share. | 30 Aug 2018 | 18,000 | 151,046 (0%) | 0% | 4.2 | 75,600 | Common Stock |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 30 Aug 2018 | 8,000 | 133,046 (0%) | 0% | 2.1 | 16,800 | Common Stock |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2018 | 18,000 | 0 | - | - | Stock Option (right to buy) | |
| Vincent Capponi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 29 Aug 2018 | 20,000 | 332,768 (1%) | 0% | 14 | 280,000 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.45 per share. | 29 Aug 2018 | 20,000 | 352,768 (1%) | 0% | 3.5 | 69,000 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Aug 2018 | 20,000 | 21,300 | - | - | Stock Option (right to buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.88 per share. | 28 Aug 2018 | 10,000 | 260,004 (0%) | 0% | 2.9 | 28,750 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2018 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.50 per share. | 28 Aug 2018 | 10,000 | 250,004 (0%) | 0% | 13.5 | 135,000 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2018 | 9,565 | 41,300 | - | - | Stock Option (right to buy) | |
| Vincent Capponi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 28 Aug 2018 | 9,565 | 332,768 (1%) | 0% | 13 | 124,345 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.75 per share. | 28 Aug 2018 | 9,565 | 342,333 (1%) | 0% | 3.8 | 35,869 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2018 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.75 per share. | 03 Aug 2018 | 6,200 | 253,604 (0%) | 0% | 12.8 | 79,050 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.85 per share. | 03 Aug 2018 | 200 | 259,804 (0%) | 0% | 12.9 | 2,570 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.15 per share. | 03 Aug 2018 | 3,600 | 250,004 (0%) | 0% | 12.2 | 43,744 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.88 per share. | 03 Aug 2018 | 10,000 | 260,004 (0%) | 0% | 2.9 | 28,750 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.45 per share. | 02 Aug 2018 | 2,835 | 335,603 (1%) | 0% | 3.5 | 9,781 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2018 | 2,835 | 58,465 | - | - | Stock Option (right to buy) | |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2018 | 7,600 | 50,865 | - | - | Stock Option (right to buy) | |
| Vincent Capponi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 02 Aug 2018 | 2,835 | 332,768 (1%) | 0% | 13 | 36,855 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.45 per share. | 02 Aug 2018 | 7,600 | 340,368 (1%) | 0% | 3.5 | 26,220 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 13.08 per share. | 02 Aug 2018 | 7,600 | 332,768 (1%) | 0% | 13.1 | 99,408 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.75 per share. | 14 Jun 2018 | 11,367 | 319,350 (1%) | 0% | 3.7 | 42,626 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2018 | 40,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2018 | 8,633 | 61,300 | - | - | Stock Option (Right to Buy) | |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2018 | 11,367 | 69,933 | - | - | Stock Option (right to buy) | |
| Vincent Capponi | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.35 per share. | 14 Jun 2018 | 15,215 | 332,768 (1%) | 0% | 12.3 | 187,905 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 14 Jun 2018 | 8,633 | 347,983 (1%) | 0% | 12 | 103,596 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 14 Jun 2018 | 11,367 | 356,616 (1%) | 0% | 12 | 136,404 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.88 per share. | 14 Jun 2018 | 40,000 | 367,983 (1%) | 0% | 0.9 | 35,000 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.75 per share. | 14 Jun 2018 | 8,633 | 327,983 (1%) | 0% | 3.8 | 32,374 | Common Stock |
| Phillip P. Chan | Director, President and CEO | 11 Jun 2018 | 8,000 | 0 | - | - | Common Stock Warrants (right to buy) | ||
| Phillip P. Chan | Director, President and CEO | 11 Jun 2018 | 8,000 | 461,281 (1%) | 0% | 3.8 | 30,000 | Common Stock | |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2018 | 8,000 | 0 | - | - | Stock Option (right to buy) | |
| Vincent Capponi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 17 May 2018 | 8,000 | 337,551 (1%) | 0% | 10 | 80,000 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.20 per share. | 17 May 2018 | 8,000 | 325,551 (1%) | 0% | 4.2 | 33,600 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 17 May 2018 | 20,000 | 317,551 (1%) | 0% | 10 | 200,000 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.88 per share. | 17 May 2018 | 20,000 | 345,551 (1%) | 0% | 0.9 | 17,500 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2018 | 20,000 | 48,000 | - | - | Stock Option (Right to Buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2018 | 12,400 | 0 | - | - | Stock Option (Right to Buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 16 May 2018 | 12,400 | 253,304 (0%) | 0% | 9 | 111,600 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.69 per share. | 16 May 2018 | 12,400 | 265,704 (0%) | 0% | 4.7 | 58,156 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.87 per share. | 16 May 2018 | 4,846 | 322,397 (1%) | 0% | 0.9 | 4,240 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2018 | 4,846 | 68,000 | - | - | Stock Option (Right to Buy) | |
| Vincent Capponi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 16 May 2018 | 4,846 | 317,551 (1%) | 0% | 9 | 43,614 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.69 per share. | 15 May 2018 | 12,400 | 265,704 (0%) | 0% | 4.7 | 58,156 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2018 | 12,400 | 12,400 | - | - | Stock Option (Right to Buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.75 per share. | 15 May 2018 | 12,400 | 253,304 (0%) | 0% | 8.8 | 108,500 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 15 May 2018 | 3,154 | 317,551 (1%) | 0% | 9 | 28,386 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 15 May 2018 | 4,000 | 320,705 (1%) | 0% | 9 | 36,000 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2018 | 3,154 | 72,846 | - | - | Stock Option (Right to Buy) | |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.20 per share. | 15 May 2018 | 4,000 | 321,551 (1%) | 0% | 4.2 | 16,800 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.88 per share. | 15 May 2018 | 3,154 | 324,705 (1%) | 0% | 0.9 | 2,760 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2018 | 4,000 | 8,000 | - | - | Stock Option (right to buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.90 per share. | 14 May 2018 | 10,000 | 263,304 (0%) | 0% | 2.9 | 29,000 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.50 per share. | 14 May 2018 | 10,000 | 253,304 (0%) | 0% | 8.5 | 85,000 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2018 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2018 | 120 | 24,800 | - | - | Stock Option (Right to Buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.69 per share. | 17 Apr 2018 | 120 | 253,424 (0%) | 0% | 4.7 | 563 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.25 per share. | 17 Apr 2018 | 120 | 253,304 (0%) | 0% | 8.3 | 990 | Common Stock |
| Al W. Kraus | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2018 | 28,875 | 28,875 | - | - | Stock Option (right to buy) | |
| Al W. Kraus | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2018 | 3,300 | 125,046 (0%) | 0% | 0 | Common Stock | |
| Edward R. Jones | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2018 | 14,450 | 14,450 | - | - | Stock Option (right to buy) | |
| Edward R. Jones | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2018 | 3,300 | 71,800 (0%) | 0% | 0 | Common Stock | |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.69 per share. | 15 Mar 2018 | 11,176 | 261,246 (0%) | 0% | 4.7 | 52,415 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2018 | 11,176 | 24,920 | - | - | Stock Option (Right to Buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2018 | 8,800 | 258,870 (0%) | 0% | 0 | Common Stock | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2018 | 93,500 | 93,500 | - | - | Stock Option (right to buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.25 per share. | 15 Mar 2018 | 11,176 | 250,070 (0%) | 0% | 8.3 | 92,202 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2018 | 10,100 | 317,551 (1%) | 0% | 0 | Common Stock | |
| Vincent Capponi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2018 | 110,350 | 110,350 | - | - | Stock Option (right to buy) | |
| Phillip P. Chan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2018 | 117,750 | 117,750 | - | - | Stock Option (right to buy) | |
| Phillip P. Chan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2018 | 10,300 | 440,713 (1%) | 0% | 0 | Common Stock | |
| Alan D. Sobel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2018 | 14,450 | 14,450 | - | - | Stock Option (right to buy) | |
| Alan D. Sobel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2018 | 3,300 | 69,300 (0%) | 0% | 0 | Common Stock | |
| Michael G. Bator | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2018 | 3,300 | 73,800 (0%) | 0% | 0 | Common Stock | |
| Michael G. Bator | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2018 | 14,450 | 14,450 | - | - | Stock Option (right to buy) | |
| Eric R. Mortensen | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2018 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Eric R. Mortensen | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2018 | 20,000 | 36,500 (0%) | 0% | 0 | Common Stock | |
| Kathleen P. Bloch | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.25 per share. | 13 Mar 2018 | 1,104 | 250,070 (0%) | 0% | 8.3 | 9,108 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2018 | 1,104 | 36,096 | - | - | Stock Option (Right to Buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.69 per share. | 13 Mar 2018 | 1,104 | 251,174 (0%) | 0% | 4.7 | 5,178 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2018 | 75,650 | 75,650 | - | - | Stock Option (right to buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2018 | 34,700 | 250,070 (0%) | 0% | 0 | Common Stock | |
| Vincent Capponi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2018 | 38,000 | 307,451 (1%) | 0% | 0 | Common Stock | |
| Vincent Capponi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2018 | 89,250 | 89,250 | - | - | Stock Option (right to buy) | |
| Phillip P. Chan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2018 | 95,200 | 95,200 | - | - | Stock Option (right to buy) | |
| Phillip P. Chan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2018 | 43,000 | 430,413 (1%) | 0% | 0 | Common Stock | |
| Eric R. Mortensen | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2018 | 14,000 | 16,500 (0%) | 0% | 0 | Common Stock | |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.90 per share. | 21 Feb 2018 | 10,000 | 268,870 (0%) | 0% | 2.9 | 29,000 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 21 Feb 2018 | 10,000 | 258,870 (0%) | 0% | 8 | 80,000 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2018 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Vincent Capponi | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.80 per share. | 16 Jan 2018 | 35,257 | 283,805 (0%) | 0% | 7.8 | 275,005 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.25 per share. | 16 Jan 2018 | 44,000 | 319,062 (1%) | 0% | 6.3 | 275,000 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2018 | 44,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2018 | 12,400 | 37,200 | - | - | Stock Option (Right to Buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.75 per share. | 12 Jan 2018 | 12,400 | 228,638 (0%) | 0% | 7.8 | 96,100 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.69 per share. | 12 Jan 2018 | 12,400 | 241,038 (0%) | 0% | 4.7 | 58,156 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2018 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.50 per share. | 08 Jan 2018 | 10,000 | 228,638 (0%) | 0% | 7.5 | 75,000 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.25 per share. | 08 Jan 2018 | 12,400 | 238,638 (0%) | 0% | 7.3 | 89,900 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.15 per share. | 08 Jan 2018 | 10,000 | 251,038 (0%) | 0% | 7.2 | 71,500 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.69 per share. | 08 Jan 2018 | 12,400 | 261,038 (0%) | 0% | 4.7 | 58,156 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.90 per share. | 08 Jan 2018 | 20,000 | 248,638 (0%) | 0% | 2.9 | 58,000 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2018 | 12,400 | 49,600 | - | - | Stock Option (Right to Buy) | |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2017 | 4,000 | 12,000 | - | - | Stock Option (Right to Buy) | |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.20 per share. | 27 Nov 2017 | 4,000 | 275,062 (0%) | 0% | 4.2 | 16,800 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 27 Nov 2017 | 4,000 | 271,062 (0%) | 0% | 7 | 28,000 | Common Stock |
| Michael G. Bator | None | Purchase of securities on an exchange or from another person at price $ 4.12 per share. | 09 Jun 2017 | 1,500 | 70,500 (0%) | 0% | 4.1 | 6,180 | Common Stock |
| Eric R. Mortensen | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 4.04 per share. | 09 Jun 2017 | 2,500 | 2,500 (0%) | 0% | 4.0 | 10,100 | Common Stock |
| Edward R. Jones | None | Purchase of securities on an exchange or from another person at price $ 3.98 per share. | 08 Jun 2017 | 500 | 500 (0%) | 0% | 4.0 | 1,988 | Common Stock |
| Edward R. Jones | None | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 08 Jun 2017 | 2,000 | 68,500 (0%) | 0% | 4.0 | 7,999 | Common Stock |
| Vincent Capponi | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 08 Jun 2017 | 2,500 | 275,062 (0%) | 0% | 4 | 10,000 | Common Stock |
| Phillip P. Chan | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 08 Jun 2017 | 3,700 | 399,907 (1%) | 0% | 4 | 14,800 | Common Stock |
| Phillip P. Chan | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 05 Jun 2017 | 6,300 | 396,207 (1%) | 0% | 4 | 25,200 | Common Stock |
| Kathleen P. Bloch | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.34 per share. | 15 May 2017 | 1,000 | 9,000 (0%) | 0% | 4.3 | 4,341 | Common Stock |
| Al W. Kraus | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 27,500 | 27,500 | - | - | Stock Option (right to buy) | |
| Al W. Kraus | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 6,000 | 121,746 (0%) | 0% | 0 | Common Stock | |
| Edward R. Jones | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 6,000 | 66,000 (0%) | 0% | 0 | Common Stock | |
| Edward R. Jones | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 13,750 | 13,750 | - | - | Stock Option (right to buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 15,700 | 228,638 (0%) | 0% | 0 | Common Stock | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 32,813 | 55,938 (0%) | 0% | 0 | Common Stock | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 89,000 | 89,000 | - | - | Stock Option (right to buy) | |
| Vincent Capponi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 17,900 | 272,562 (1%) | 0% | 0 | Common Stock | |
| Vincent Capponi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 35,938 | 75,662 (0%) | 0% | 0 | Common Stock | |
| Vincent Capponi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 105,000 | 105,000 | - | - | Stock Option (right to buy) | |
| Phillip P. Chan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 40,625 | 184,207 (0%) | 0% | 0 | Common Stock | |
| Phillip P. Chan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 112,000 | 112,000 | - | - | Stock Option (right to buy) | |
| Phillip P. Chan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 18,700 | 389,907 (1%) | 0% | 0 | Common Stock | |
| Robert Bartlett | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Alan D. Sobel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 6,000 | 66,000 (0%) | 0% | 0 | Common Stock | |
| Alan D. Sobel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 13,750 | 13,750 | - | - | Stock Option (right to buy) | |
| Michael G. Bator | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 13,750 | 13,750 | - | - | Stock Option (right to buy) | |
| Michael G. Bator | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 6,000 | 69,000 (0%) | 0% | 0 | Common Stock | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2017 | 62,000 | 62,000 | - | - | Stock Option (right to buy) | |
| Vincent Capponi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2017 | 73,200 | 73,200 | - | - | Stock Option (right to buy) | |
| Phillip P. Chan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2017 | 77,600 | 77,600 | - | - | Stock Option (right to buy) | |
| Robert Bartlett | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2017 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Phillip P. Chan | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 Dec 2016 | 4,600 | 448,103 | - | - | Common Stock | |
| Kathleen P. Bloch | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 06 Dec 2016 | 1,000 | 8,000 | - | - | Common Stock | |
| Phillip P. Chan | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Aug 2016 | 5,000 | 121,648 | - | - | Common Stock | |
| Al W. Kraus | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2016 | 5,000 | 60,746 | - | - | Common Stock | |
| Al W. Kraus | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2016 | 24,000 | 24,000 | - | - | Stock Option (right to buy) | |
| Edward R. Jones | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2016 | 5,000 | 5,000 | - | - | Common Stock | |
| Edward R. Jones | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2016 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2016 | 77,500 | 77,500 | - | - | Stock Option (right to buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2016 | 5,600 | 5,600 | - | - | Stock Option (right to buy) | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2016 | 21,000 | 23,125 | - | - | Common Stock | |
| Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2016 | 47,000 | 70,125 | - | - | Common Stock | |
| Vincent Capponi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2016 | 23,000 | 39,724 | - | - | Common Stock | |
| Vincent Capponi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2016 | 91,500 | 91,500 | - | - | Stock Option (right to buy) | |
| Vincent Capponi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2016 | 6,600 | 6,600 | - | - | Stock Option (right to buy) | |
| Vincent Capponi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2016 | 54,000 | 93,724 | - | - | Common Stock | |
| Phillip P. Chan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2016 | 7,000 | 7,000 | - | - | Stock Option (right to buy) | |
| Phillip P. Chan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2016 | 97,000 | 97,000 | - | - | Stock Option (right to buy) | |
| Phillip P. Chan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2016 | 26,000 | 133,982 | - | - | Common Stock | |
| Phillip P. Chan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2016 | 57,000 | 190,982 | - | - | Common Stock | |
| Robert Bartlett | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2016 | 2,000 | 2,000 | - | - | Stock Option (right to buy) | |
| Robert Bartlett | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2016 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Alan D. Sobel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2016 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Alan D. Sobel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2016 | 5,000 | 5,000 | - | - | Common Stock | |
| Michael G. Bator | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2016 | 60,000 | 63,000 | - | - | Common Stock | |
| Michael G. Bator | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 07 Jun 2016 | 3,000 | 3,000 | - | - | Common Stock | |
| Michael G. Bator | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2016 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Michael G. Bator | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2016 | 1,000 | 2,000 | - | - | Common Stock | |
| Michael G. Bator | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2016 | 1,000 | 1,000 | - | - | Common Stock | |
| Kathleen P. Bloch | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 Dec 2015 | 2,125 | 2,125 | - | - | Common Stock | |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2015 | 4,000 | 76,000 | - | - | Stock Option | |
| Vincent Capponi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2015 | 4,000 | 20,724 | - | - | Common Stock | |
| Vincent Capponi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Oct 2015 | 4,000 | 16,724 | - | - | Common Stock | |
| Phillip P. Chan | Director, President and CEO | 19 Oct 2015 | 667 | 0 | - | - | Warrant (right to buy) | ||
| Phillip P. Chan | Director, President and CEO | 19 Oct 2015 | 2,000 | 75,443 | - | - | Common Stock | ||
| Phillip P. Chan | Director, President and CEO | 19 Oct 2015 | 800 | 73,442 | - | - | Common Stock | ||
| Phillip P. Chan | Director, President and CEO | 19 Oct 2015 | 667 | 72,643 | - | - | Common Stock | ||
| Phillip P. Chan | Director, President and CEO | 19 Oct 2015 | 2,000 | 0 | - | - | Warrant (right to buy) | ||
| Phillip P. Chan | Director, President and CEO | 19 Oct 2015 | 800 | 0 | - | - | Warrant (right to buy) | ||
| Al W. Kraus | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Oct 2015 | 6,774 | 55,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2015 | 6,774 | 62,520 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2015 | 10,000 | 0 | - | - | Stock Option | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2015 | 10,000 | 6,774 | - | - | Stock Option | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2015 | 10,000 | 65,746 | - | - | Common Stock | |
| Al W. Kraus | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 08 Oct 2015 | 10,000 | 55,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2015 | 10,000 | 26,773 | - | - | Stock Option | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2015 | 10,000 | 65,746 | - | - | Common Stock | |
| Al W. Kraus | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Oct 2015 | 10,000 | 55,746 | - | - | Common Stock | |
| Al W. Kraus | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 24 Sep 2015 | 10,000 | 55,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2015 | 10,000 | 36,773 | - | - | Stock Option | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2015 | 10,000 | 65,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Sep 2015 | 10,000 | 46,773 | - | - | Stock Option | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Sep 2015 | 10,000 | 65,746 | - | - | Common Stock | |
| Al W. Kraus | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 17 Sep 2015 | 10,000 | 55,746 | - | - | Common Stock | |
| Al W. Kraus | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 10 Sep 2015 | 10,000 | 55,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2015 | 10,000 | 56,773 | - | - | Stock Option | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2015 | 10,000 | 65,746 | - | - | Common Stock | |
| Phillip P. Chan | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 09 Sep 2015 | 19,757 | 107,982 | - | - | Common Stock | |
| Phillip P. Chan | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 09 Sep 2015 | 2,903 | 88,225 | - | - | Common Stock | |
| Phillip P. Chan | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 09 Sep 2015 | 9,879 | 85,322 | - | - | Common Stock | |
| Al W. Kraus | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 03 Sep 2015 | 10,000 | 55,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2015 | 10,000 | 66,773 | - | - | Stock Option | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2015 | 10,000 | 65,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2015 | 10,000 | 76,773 | - | - | Stock Option | |
| Al W. Kraus | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 27 Aug 2015 | 10,000 | 55,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2015 | 10,000 | 65,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2015 | 10,000 | 86,773 | - | - | Stock Option | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2015 | 10,000 | 65,746 | - | - | Common Stock | |
| Al W. Kraus | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 20 Aug 2015 | 10,000 | 55,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2015 | 10,000 | 96,773 | - | - | Stock Option | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2015 | 10,000 | 65,746 | - | - | Common Stock | |
| Al W. Kraus | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 13 Aug 2015 | 10,000 | 55,746 | - | - | Common Stock | |
| Al W. Kraus | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 06 Aug 2015 | 10,000 | 55,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 10,000 | 65,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 10,000 | 106,773 | - | - | Stock Option | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2015 | 10,000 | 116,773 | - | - | Stock Option | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2015 | 10,000 | 65,746 | - | - | Common Stock | |
| Al W. Kraus | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 Jul 2015 | 10,000 | 55,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2015 | 10,000 | 126,773 | - | - | Stock Option | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2015 | 10,000 | 65,746 | - | - | Common Stock | |
| Al W. Kraus | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 23 Jul 2015 | 10,000 | 55,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2015 | 10,000 | 136,773 | - | - | Stock Option | |
| Al W. Kraus | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 Jul 2015 | 10,000 | 55,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2015 | 10,000 | 65,746 | - | - | Common Stock | |
| Michael G. Bator | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2015 | 6,000 | 6,000 | - | - | Stock Option | |
| Al W. Kraus | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 09 Jul 2015 | 10,000 | 55,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2015 | 10,000 | 65,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2015 | 10,000 | 146,773 | - | - | Stock Option | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2015 | 10,000 | 65,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2015 | 10,000 | 156,773 | - | - | Stock Option | |
| Al W. Kraus | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Jul 2015 | 10,000 | 55,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2015 | 3,205 | 0 | - | - | Stock Option | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2015 | 10,000 | 166,773 | - | - | Stock Option | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2015 | 3,205 | 58,746 | - | - | Common Stock | |
| Al W. Kraus | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 24 Jun 2015 | 3,205 | 55,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2015 | 10,000 | 65,746 | - | - | Common Stock | |
| Al W. Kraus | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 24 Jun 2015 | 10,000 | 55,746 | - | - | Common Stock | |
| Al W. Kraus | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Jun 2015 | 10,000 | 55,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2015 | 10,000 | 166,773 | - | - | Stock Option | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2015 | 10,000 | 65,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2015 | 10,000 | 176,773 | - | - | Stock Option | |
| Al W. Kraus | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Jun 2015 | 10,000 | 55,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2015 | 10,000 | 65,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2015 | 10,000 | 186,773 | - | - | Stock Option | |
| Al W. Kraus | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Jun 2015 | 10,000 | 55,746 | - | - | Common Stock | |
| Al W. Kraus | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2015 | 10,000 | 65,746 | - | - | Common Stock |